date/time interval
- April 1, 2017 - March 31, 2018
Development of Molecularly Targeted Ultrasound Contrast Agents for Prostate Cancer Imaging using Bioorthogonal Chemistry
Grant
- Overview
- Affiliation
- View All
Overview
awarded by
total award amount
- CAD 200500